Navigation Links
Microbia Announces Name Change to Ironwood Pharmaceuticals
Date:4/7/2008

CAMBRIDGE, Mass., April 7, 2008 /PRNewswire/ -- Microbia, Inc. today announced that it has changed its name to Ironwood Pharmaceuticals, Inc. The ironwood is a long-lived tree that thrives in the harshest desert environment, with some trees surviving as long as 1,500 years. Known as a "nurse tree," it provides a shaded microclimate with lower temperatures, higher water availability, and more organic matter for birds, reptiles, insects, animals, and plants. In addition, the name Ironwood encompasses the inorganic and organic -- the properties of essential elements and the characteristics of life.

"As Microbia has developed and progressed, we have outgrown the usefulness of the name Microbia," said Peter Hecht, CEO. "With that in mind, we sought a name for the company that reflects our approach to creating important human medicines. Because our research efforts are not limited to a single therapeutic area, we require a name that will accommodate a broad range of discoveries and products. We chose a name that not only suits us today, but also can endure for 100 years."

Additional information can be found at http://www.ironwoodpharma.com.

About Ironwood Pharmaceuticals (formerly Microbia)

Ironwood Pharmaceuticals (http://www.ironwoodpharma.com) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. The Company is advancing several clinical candidates -- linaclotide for the treatment of irritable bowel syndrome with constipation, chronic constipation and other functional gastrointestinal disorders; and novel, next-generation cholesterol absorption inhibitors for the treatment of hypercholesterolemia. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia Precision Engineering, Inc., a majority-owned subsidiary of Ironwood Pharmaceuticals is an industrial biotechnology company developing and commercializing novel bioprocesses for the production of specialty chemicals. Ironwood has raised $231 million in private equity financing and is located in Cambridge, Massachusetts.

Contact:

Susan Brady

Corporate Communications

617|621-8304

sbrady@ironwoodpharma.com


'/>"/>
SOURCE Microbia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Microbial Genome-to-Array Service
2. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
3. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
4. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
5. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
6. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. Medicsight Announces New Marketing Partnership with INFINITT
9. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
10. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
11. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... II Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). ... two years to develop a suite of BioGel™ biopolymer materials for hygiene applications, ...
(Date:3/28/2017)... 2017  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member. David Cox ... North America ), will serve as his ... "We,re pleased to have Ipsen and Dr. Cox join ... . "We welcome their insights in helping us identify ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently ... over time. A recent study published in STEM CELLS suggests that human neural ... (SVZ) stem cells to produce more neural cells. , Strategies involving transplantation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search ... with Avomeen Analytical Services. Harvill is a distinguished life sciences expert with a ... is a leader in a wide range of services related to laboratory testing ...
Breaking Biology Technology:
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... 2017 Vigilant Solutions , a vehicle ... agencies, announced today the appointment of retired FBI special ... safety business development. Mr. Sheridan brings more ... a focus on the aviation transportation sector, to his ... Mr. Sheridan served as the Aviation Liaison Agent Coordinator ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):